500 related articles for article (PubMed ID: 16844683)
1. Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231).
Martins SM; Frosoni DJ; Martinez AM; De Felice FG; Ferreira ST
J Biol Chem; 2006 Sep; 281(36):26121-8. PubMed ID: 16844683
[TBL] [Abstract][Full Text] [Related]
2. Amyloid core formed of full-length recombinant mouse prion protein involves sequence 127-143 but not sequence 107-126.
Chatterjee B; Lee CY; Lin C; Chen EH; Huang CL; Yang CC; Chen RP
PLoS One; 2013; 8(7):e67967. PubMed ID: 23844138
[TBL] [Abstract][Full Text] [Related]
3. PrP N-terminal domain triggers PrP(Sc)-like aggregation of Dpl.
Erlich P; Cesbron JY; Lemaire-Vieille C; Curt A; Andrieu JP; Schoehn G; Jamin M; Gagnon J
Biochem Biophys Res Commun; 2008 Jan; 365(3):478-83. PubMed ID: 17997980
[TBL] [Abstract][Full Text] [Related]
4. Autocatalytic conversion of recombinant prion proteins displays a species barrier.
Baskakov IV
J Biol Chem; 2004 Feb; 279(9):7671-7. PubMed ID: 14668351
[TBL] [Abstract][Full Text] [Related]
5. In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features.
Baskakov IV; Bocharova OV
Biochemistry; 2005 Feb; 44(7):2339-48. PubMed ID: 15709746
[TBL] [Abstract][Full Text] [Related]
6. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions.
Lührs T; Zahn R; Wüthrich K
J Mol Biol; 2006 Mar; 357(3):833-41. PubMed ID: 16466741
[TBL] [Abstract][Full Text] [Related]
7. Aggregation and amyloid fibril formation induced by chemical dimerization of recombinant prion protein in physiological-like conditions.
Roostaee A; Côté S; Roucou X
J Biol Chem; 2009 Nov; 284(45):30907-16. PubMed ID: 19710507
[TBL] [Abstract][Full Text] [Related]
8. Shaking alone induces de novo conversion of recombinant prion proteins to β-sheet rich oligomers and fibrils.
Ladner-Keay CL; Griffith BJ; Wishart DS
PLoS One; 2014; 9(6):e98753. PubMed ID: 24892647
[TBL] [Abstract][Full Text] [Related]
9. Assembly of the full-length recombinant mouse prion protein I. Formation of soluble oligomers.
Vendrely C; Valadié H; Bednarova L; Cardin L; Pasdeloup M; Cappadoro J; Bednar J; Rinaudo M; Jamin M
Biochim Biophys Acta; 2005 Aug; 1724(3):355-66. PubMed ID: 15975719
[TBL] [Abstract][Full Text] [Related]
10. How does domain replacement affect fibril formation of the rabbit/human prion proteins.
Yan X; Huang JJ; Zhou Z; Chen J; Liang Y
PLoS One; 2014; 9(11):e113238. PubMed ID: 25401497
[TBL] [Abstract][Full Text] [Related]
11. Wild-type Shadoo proteins convert to amyloid-like forms under native conditions.
Daude N; Ng V; Watts JC; Genovesi S; Glaves JP; Wohlgemuth S; Schmitt-Ulms G; Young H; McLaurin J; Fraser PE; Westaway D
J Neurochem; 2010 Apr; 113(1):92-104. PubMed ID: 20067571
[TBL] [Abstract][Full Text] [Related]
12. Cryo-EM structure of an amyloid fibril formed by full-length human prion protein.
Wang LQ; Zhao K; Yuan HY; Wang Q; Guan Z; Tao J; Li XN; Sun Y; Yi CW; Chen J; Li D; Zhang D; Yin P; Liu C; Liang Y
Nat Struct Mol Biol; 2020 Jun; 27(6):598-602. PubMed ID: 32514176
[TBL] [Abstract][Full Text] [Related]
13. Electron paramagnetic resonance evidence for binding of Cu(2+) to the C-terminal domain of the murine prion protein.
Cereghetti GM; Schweiger A; Glockshuber R; Van Doorslaer S
Biophys J; 2001 Jul; 81(1):516-25. PubMed ID: 11423433
[TBL] [Abstract][Full Text] [Related]
14. Structural Mechanism of Barriers to Interspecies Seeding Transmissibility of Full-Length Prion Protein Amyloid.
Ma T; Deng J; Ma S; Zhao W; Chang Z; Yu K; Yang J
Chembiochem; 2019 Nov; 20(21):2757-2766. PubMed ID: 31161647
[TBL] [Abstract][Full Text] [Related]
15. Assembly of natural and recombinant prion protein into fibrils.
Leffers KW; Wille H; Stöhr J; Junger E; Prusiner SB; Riesner D
Biol Chem; 2005 Jun; 386(6):569-80. PubMed ID: 16006244
[TBL] [Abstract][Full Text] [Related]
16. Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure.
Cobb NJ; Sönnichsen FD; McHaourab H; Surewicz WK
Proc Natl Acad Sci U S A; 2007 Nov; 104(48):18946-51. PubMed ID: 18025469
[TBL] [Abstract][Full Text] [Related]
17. Cu(II) induces small-size aggregates with amyloid characteristics in two alleles of recombinant ovine prion proteins.
Tsiroulnikov K; Rezaei H; Dalgalarrondo M; Chobert JM; Grosclaude J; Haertlé T
Biochim Biophys Acta; 2006 Jul; 1764(7):1218-26. PubMed ID: 16777497
[TBL] [Abstract][Full Text] [Related]
18. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
Walsh P; Simonetti K; Sharpe S
Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
[TBL] [Abstract][Full Text] [Related]
19. Influence of phosphorus dendrimers on the aggregation of the prion peptide PrP 185-208.
Klajnert B; Cortijo-Arellano M; Cladera J; Majoral JP; Caminade AM; Bryszewska M
Biochem Biophys Res Commun; 2007 Dec; 364(1):20-5. PubMed ID: 17927954
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen/deuterium exchange mass spectrometry identifies two highly protected regions in recombinant full-length prion protein amyloid fibrils.
Nazabal A; Hornemann S; Aguzzi A; Zenobi R
J Mass Spectrom; 2009 Jun; 44(6):965-77. PubMed ID: 19283723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
